Gujarat Themis Biosyn Limited
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Gujarat Themis Biosyn Limited is publicly traded on NSE under the ticker GUJTHEM.NS.
Gujarat Themis Biosyn Ltd. is an Indian company primarily involved in the creation of pharmaceuticals and medicinal chemicals. The firm also supplies bulk drugs via a job work model within India. Its product offerings include important compounds such as Rifamycin-S, an intermediate used in treatments for tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease. Another key product, Rifamycin-O,...
Can you invest in Gujarat Themis Biosyn Limited?
Yes. Gujarat Themis Biosyn Limited is publicly traded on NSE under the ticker GUJTHEM.NS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Gujarat Themis Biosyn Limited
Detailed equity research is provided by MarketSnap.